Last updated on May 2016

ACE-CL-007: Study of Obinutuzumab + Chlorambucil, ACP-196 + Obinutuzumab, and ACP-196 Monotherapy in Subjects With Previously Untreated CLL

Other Details:

Contact: 1-888-292-9613 or

Acerta Pharma BV

Study Director: Jane Huang, MD Acerta Pharma BV

Find a site near you

Start Over

Debreceni Egyetem Klinikai Kozpont

Located in: Debrecen, XX Hungary
  Connect »